These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34114732)

  • 21. Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.
    Aragon-Ching JB; Nizam A; Henson DE
    Clin Genitourin Cancer; 2019 Dec; 17(6):436-442. PubMed ID: 31445851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New malignancies following cancer of the urinary bladder: analysis of German cancer registry data.
    Lehnert M; Kraywinkel K; Pesch B; Holleczek B; Brüning T
    Eur J Cancer Care (Engl); 2012 May; 21(3):398-402. PubMed ID: 22151945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
    Kerroumi S; Neuzillet Y; Soorojebally Y; Radulescu C; Talhi R; Taleb S; Herve CJ; Rouanne M; Abdou A; Bosset P; Bazzi A; Yousfi MJ; Lebret T
    Urol Oncol; 2021 Aug; 39(8):497.e1-497.e8. PubMed ID: 33579627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer.
    Jahreiß MC; Incrocci L; Aben KKH; De Vries KC; Hoogeman M; Hooning MJ; Heemsbergen WD
    Acta Oncol; 2024 Jun; 63():511-517. PubMed ID: 38946286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinical study of renal pelvic and ureteral cancer associated with bladder cancer].
    Sakaue K; Kakimoto K; Oda M; Kajikawa J; Koide T; Kobayashi Y
    Hinyokika Kiyo; 1996 Feb; 42(2):91-4. PubMed ID: 8712094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
    Feller A; Matthes KL; Bordoni A; Bouchardy C; Bulliard JL; Herrmann C; Konzelmann I; Maspoli M; Mousavi M; Rohrmann S; Staehelin K; Arndt V;
    BMC Cancer; 2020 Jan; 20(1):51. PubMed ID: 31964352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers.
    Zheng G; Sundquist K; Sundquist J; Chen T; Försti A; Hemminki O; Hemminki K
    Eur Urol Open Sci; 2021 Feb; 24():52-59. PubMed ID: 34337496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    Wang Q; Zhang T; Wu J; Wen J; Tao D; Wan T; Zhu W
    BMC Urol; 2019 Apr; 19(1):24. PubMed ID: 30999871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the development of bladder cancer after upper tract urothelial cancer.
    Hisataki T; Miyao N; Masumori N; Takahashi A; Sasai M; Yanase M; Itoh N; Tsukamoto T
    Urology; 2000 May; 55(5):663-7. PubMed ID: 10792075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative risk of second primary cancers in Austria's western states: a retrospective cohort study.
    Preyer O; Concin N; Obermair A; Concin H; Ulmer H; Oberaigner W
    BMC Cancer; 2017 Oct; 17(1):699. PubMed ID: 29065867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
    Luo HL; Kang CH; Chen YT; Chuang YC; Cheng YT; Lee WC; Chiang PH
    Int J Urol; 2014 Apr; 21(4):366-9. PubMed ID: 24118071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000-2015: Population-based analysis.
    Odani S; Tabuchi T; Nakata K; Morishima T; Kuwabara Y; Koyama S; Kudo H; Kato M; Miyashiro I
    Cancer Med; 2022 Jan; 11(2):507-519. PubMed ID: 34845852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.